# Filipa Lynce, M.D. – FDA Inspection, Oct 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/filipa-lynce-md/54276b1a-0cc1-4a74-9f0a-b9bc1f647c9d
Source feed: FDA_Inspections

> FDA inspection 1287944 of Filipa Lynce, M.D., October 21, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1287944
- Company Name: Filipa Lynce, M.D.
- Inspection Date: 2025-10-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1135746 - 2021-01-29

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/filipa-lynce-md/8bfcb49f-49c9-456a-8449-5bbec827b8e6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
